However, the shelf life after reconstitution varies with the biologic. Efalizumab can be ... Areas with bruising, redness, open sores, or psoriasis plaques should be avoided.

Based on the immunopathology of psoriasis, we have proposed a model for biologic therapeutic approaches that identifies four mechanistic strategies. [25] A host of targeted immunologic ...

Psoriasis, in its most severe presentation, is a candidate for biologic and biosimilar medications. These medications represent “stage 3” treatments for situations where topical, phototherapy ...

or the time from first conventional therapy to biologic therapy initiation in patients with psoriasis. Previous use of conventional systemic therapy does not significantly impact subsequent biologic ...

Flakes won’t go away? You might be dealing with scalp psoriasis instead of dandruff! Here's how to know the difference ...

Opens in a new tab or window Researchers have designed a new resource for prescribing biologics to patients with psoriasis. The report covers TNF-α inhibitors, as well as IL-12, IL-17 ...

This study investigates the therapeutic effectiveness and timeline for skin lesion resolution in plaque psoriasis patients treated with combined biologic agents compared to standard therapies. Methods ...

The approvals add two more options for psoriasis patients hoping to stay away from biologics as long as they can. If symptoms remain mild to moderate, patients can stay on these drugs indefinitely.